B Sole-Source-Justification-FS.pdf

Revised10/31/2016

FAR Subpart 13.106-1(b)

SOLE-SINGLE SOURCE (including Brand-Name) JUSTIFICATION

“Source Selection Information – see FAR 2.101 and 3.104”

1. Identification of the Agency and Contracting Activity.

a. Federal Agency and Contracting Activity.

Department of Health and Human Services National Institute of Health National Institute on Drug Abuse

b. Sponsoring Organization.

• National Center for Advancing Translational Sciences (NCATS)

• Office of Strategic Alliances (OSA)

c. Project Officer Information.

• Project Officer Name. Mayra Alvarez Lopez

• Mailing Address. 9800 Medical Center Dr. Building B Rockville, MD

20852

• E-mail Address. Mayra@nih.gov

• Telephone Number. 301-827-7146

2. Project Description.

a. Name of Item or Project Title.

Biomedtracker

b. Description of the Item or Service.

Biomedtracker is the leading business intelligence service, powering sales, licensing and mergers and acquisitions for the life science industry. Their wide selction of datasets and flexible, intuitive interface compiles search data into a single, customizable view that makes it simple to access actionable information.

Key Uses of Biomedtracker:

• Indentify drug development partners

• Build market models and sales forecasts

• Analyze research and development spending

• Screen potential licensing and investment opportunities

• Ensure accurate valuations of products and technologies

• Identify and evaluate now CMO and CRO projects

Support Tools:

mailto:Mayra@nih.gov

• Pipeline Analyzer: Identlifies products in development and milestones that lie ahead

• Patent Analyzer:Monitors events that may change the market and future forecast development

• Deals/Alliances: Identifes key buyers and sellers in the market

• Venture/Finance: Determine which companies are securing funding and who is providing funding in your market.

Reporting Tools:

• Chemical Structure Search

• Epidemiology Tool

• Milestone Analyzer

• Royalty Explorer

• Product Sales Analyzer

• R&D Spending Analyzer

• Merger Tool

• Financial Explorer

3. Market Research (see FAR Part 1 0).

Market Research was conducted and the results of market research are detailed in the attached market research document.

4. Acquisition Type.

This acquisition exceeds $5,000 and not expected to exceed $250,000, and conducted in accordance with FAR Part 13—Simplified Acquisition Procedures.

5. Acquisition Authority. This acquisition is conducted under the authority of the Federal Acquisition Regulations (FAR) Subpart 13.106-1 (b) Soliciting from a single source. (1) For purchases not exceeding the simplified acquisition threshold, contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, or industrial mobilization).

6. Justification Rationale.

The Office of Strategic Alliances’ (OSA) mission and mandate is to make it as easy as possible for industry and academia to collaborate and partner up with the Center’s science programs and scientists. OSA provides a complete array of services to support NCATS’ technology development and partnership activities with other NIH Institutes and Centers, universities, nonprofits, pharmaceuticals, biotechnology firms and small business. One of OSA’s main roles is to address intellectual property (IP) issues by reviewing and tracking new innovations and developing strategies for patent filing and partnering. OSA’s other main role is to facilitate the commercialization of its technologies by licensing to outside partners. With Pharma Intelligence – Informa - Biomedtracker services DPI scientist/ applicable staff as well as our Licensing and Patenting Managers (LPM) would be able to conduct research for partnership opportunities, by searching to see whether a new innovation/technology being developed at NCATS is already being developed elsewhere (e.g. Pharma or academia) and if so what the terms of the deal were. Biomedtracker will also allow OSA to conduct research on the innovations/technologies already out on the market.

Only one source is available:

I hereby determine that the Biomedtracker listed herein is available from only one source, and competition is precluded for the reasons indicated below. There are no substitutes available.

This acquisition is restricted to CiteLine - Carrus US 1 Inc. - 605 3rd Avenue, 22nd floor, New York, NY 10158. Brett Sinofsky brett.sinofsky@informa.com (347) 831-4987

The estimated cost of the required item or service is $26,870.00, Exclusive licensing or industrial mobilization:

A patent, copyright, proprietary data, or licensing agreement limits competition. The product is a commercial off-the-shelf (COTS) data service that is subject to exclusive licensing.

7. Any other facts supporting the justification.

N/A

8. Project Officer Certification. The undersigned program official(s) certifies that the information in support of this justification for the proposed acquisition has been reviewed, is completed and correct to the best of my knowledge and belief and recommends approval.

mailto:brett.sinofsky@informa.com

Project Officer Date

9. Contracting Officer Certification. The Contracting Officer certifies that the justification for the proposed acquisition has been reviewed and that to the best of my knowledge and belief the information and/or data provided to support the rationale and recommendation for approval is accurate and complete and in accordance with FAR 13.106-1(b)(1), the facts of this acquisition preclude the use of full and open competition.

Contracting Officer Date

“Source Selection Information – see FAR 2.101 and 3.104”